First Level Socio-geriatric Evaluation: ESOGER Databank
1 other identifier
observational
20,000
1 country
1
Brief Summary
Coronavirus disease 2019 (COVID-19) is an infectious disease. Physical distancing is one of the most effective ways to reduce the spread of COVID-19, but this key prevention intervention may have adverse consequences on older adults living at home. Screening older adults living at home and at risk for adverse consequences of physical and social distancing is, therefore, a priority in order to prevent their occurrence. ESOGER ("Evaluation Social et GERiatrique") is a clinical tool designed to: 1) screen the risk-levels for adverse consequences related to COVID-19 physical distancing and 2) to continue appropriate preventive interventions in older adults living at home including frail older patients and older community dwellers. Experience cumulated during the past two weeks revealed that ESOGER could be improved, in order to be more effective and efficient for the prevention of adverse consequences related to COVID-19 physical distancing. This improvement is based on two key components: 1) Comments of Montreal ESOGER users and 2) Analysis of data. Because at this time no information is saved and stored, there is a need to save and store ESOGER information and create the ESOGER databank.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 20, 2020
CompletedFirst Submitted
Initial submission to the registry
May 13, 2020
CompletedFirst Posted
Study publicly available on registry
May 19, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 19, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 19, 2027
February 23, 2024
February 1, 2024
7 years
May 13, 2020
February 22, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
COVID-19 symptoms
presence or not of fever, cough and shortness of breath (binary question)
1 day
issues related to medication and food delivery and access to home care
presence or not of a rupture of access to food, medication and home care (binary question)
1 day
physical frailty
Questionnaire Emergency Room Evaluation and Recommandation (ER2), score from 0 = no risk of frailty to 14 = high risk of frailty)
1 day
psychological frailty
anxiety Verbal analogic scale, score from 0 = no anxiety to 10 = extremely anxious)
1 day
Secondary Outcomes (1)
Caregiver burden
1 day
Study Arms (1)
Older patients / community dwellers
The inclusion criteria are: 1. Older (i.e., 70-years-old and over) adults OR caregiver living at home with an adult answering to inclusion criteria 2. Living and staying at home because of physical and social distancing 3. Understanding and writing the different languages of the recruitment centre (i.e., French, English, Chinese.) 4. Agree to participate in the study The exclusion criteria are: 1. A concomitant participation to another medical trial 2. Living in semi-autonomous residence or CHSLD
Interventions
Eligibility Criteria
All the older patients and community dwellers living at home in Montreal contacted by the researchers and corresponding to the criteria. The project is about a constitution of a databank.
You may qualify if:
- Living and staying at home because of physical and social distancing
- Understanding and writing the different languages of the recruitment centre (i.e., French, English, Chinese.)
- Agree to participate in the study
You may not qualify if:
- A concomitant participation to another medical trial
- Living in semi-autonomous residence or CHSLD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jewish General Hospital
Montreal, Quebec, H3T 1E2, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior clinician researcher
Study Record Dates
First Submitted
May 13, 2020
First Posted
May 19, 2020
Study Start
April 20, 2020
Primary Completion (Estimated)
April 19, 2027
Study Completion (Estimated)
April 19, 2027
Last Updated
February 23, 2024
Record last verified: 2024-02